University of Illinois Chicago
Chicago, Illinois, 60612, United States
NCT Number: NCT03867773
The aims of this proposal are to compare the effects of 4-h versus 6-h time restricted feeding (TRF) on body weight and metabolic disease risk factors in adults with obesity. To test the study objectives, a 10-week randomized, controlled, parallel-arm trial, divided into 2 consecutive periods: (1) 2-week baseline period; and (2) 8-week TRF weight loss period, will be implemented. Obese subjects will be randomized to 1 of 3 groups: (1) 4-h TRF, (2) 6-h TRF, or a no-intervention control group. This study will be the first randomized controlled trial to compare 4-h versus 6-h TRF.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60612, United States
Modest weight loss of 5-10% is sufficient to reduce metabolic disease risk in obese individuals. The first line of therapy prescribed for weight loss is daily calorie restriction (CR; 25% restriction every day). However, adherence to CR greatly diminishes after 4-6 weeks, due to subject frustration with constantly having to count calories and never being able to eat freely. In light of these issues with CR, another approach that limits timing of food intake, instead of number of calories consumed, has been developed. This strategy is termed time restricted feeding (TRF), and involves confining the period of food intake to 8 h/d (10 am to 6 pm) without calorie counting. Preliminary findings of 8-h TRF demonstrate modest weight loss and blood pressure reductions after 12 weeks. What remains unknown however, is whether shorter feeding windows during TRF (such as 4-h or 6-h feeding windows) can produce even greater weight loss in obese adults. Also of interest, is the impact of these shorter feeding windows on metabolic disease risk indicators (such as plasma lipids, blood pressure, and insulin resistance, inflammation and oxidative stress). Accordingly, the aims of this proposal are: AIM 1: To compare the effects of 4-h versus 6-h time restricted feeding (TRF) on body weight in adults with obesity; AIM 2: To compare the effects of 4-h versus 6-h TRF on metabolic disease risk factors in adults with obesity. To test the study objectives, a 10-week randomized, controlled, parallel-arm trial, divided into 2 consecutive periods: (1) 2-week baseline period; and (2) 8-week TRF weight loss period, will be implemented. Obese subjects will be randomized to 1 of 3 groups: (1) 4-h TRF, (2) 6-h TRF, or a no-intervention control group. This study will be the first randomized controlled trial to compare 4-h versus 6-h TRF on body weight and metabolic disease risk markers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
TRF subjects will consume food ad libitum during the feeding window (4-h or 6-h window), and refrain from eating during the fasting window (20-h or 18-h window)
Time frame: Measured at week 1 and 8
Measured by an electronic scale
Time frame: Measured at week 1 and 8
Measured by DXA
Time frame: Measured at week 1 and 8
Measured as HOMA-IR
Time frame: Measured at week 1 and 8
Measured with a hexokinase reagent kit
Time frame: Measured at week 1 and 8
Measured as total immunoreactive insulin
Time frame: Measured at week 1 and 8
Measured by a blood pressure cuff
Time frame: Measured weekly from baseline to week 8
Measured by questionnaire
Time frame: Measured at week 1 and 8
Measured by outside lab (Medstart, IN)
Time frame: Measured at week 1 and 8
Measured by a blood pressure cuff
Time frame: Measured at week 1 and 8
Measured by ELISA
Time frame: Measured at week 1 and 8
Measured by ELISA
Time frame: Measured at week 1 and 8
Measured by food record
Time frame: Measured at week 1 and 8
Measured by activity monitor
Time frame: Measured weekly from baseline to week 8
Measured by a questionnaire
Time frame: Measured at week 1 and 8
Measured by a questionnaire
Time frame: Measured at week 1 and 8
Measured by a questionnaire
Time frame: Measured at week 1 and 8
Measured by a questionnaire
Time frame: Measured at week 1 and 8
Measured by a ELISA
University of Illinois at Chicago
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00065676
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT00862433
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT01809288
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT01501201
Body Weight, Diabetes
Lille, Nord, France
View Trial Details